We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 1,566 results
  1. Brain-specific Pd1 deficiency leads to cortical neurogenesis defects and depressive-like behaviors in mice

    Embryonic neurogenesis is tightly regulated by multiple factors to ensure the precise development of the cortex. Deficiency in neurogenesis may...

    Fen Ji, Chao Feng, ... Jianwei Jiao in Cell Death & Differentiation
    Article 08 August 2023
  2. FSTL3 promotes tumor immune evasion and attenuates response to anti-PD1 therapy by stabilizing c-Myc in colorectal cancer

    Programmed cell death 1 ligand 1 (PDL1)/programmed cell death 1 (PD1) blockade immunotherapy provides a prospective strategy for the treatment of...

    Haiyang Li, Na Zheng, ... Shuli Zhao in Cell Death & Disease
    Article Open access 01 February 2024
  3. Genomic Profiling Reveals Immune-Related Gene Differences in Lung Cancer Patients Stratified by PD1/PDL1 Expression: Implications for Immunotherapy Efficacy

    Lung cancer remains a leading cause of global cancer-related mortality, and the exploration of innovative therapeutic approaches, such as PD1/PDL1...

    Zhifeng Ye, Ting Huang, ... Lu Wang in Journal of Applied Genetics
    Article 16 February 2024
  4. PD1 blockade improves survival and CD8+ cytotoxic capacity, without increasing inflammation, during normal microbial experience in old mice

    By 2030, individuals 65 years of age or older will make up approximately 20% of the world’s population 1 . Older individuals are at the highest risk...

    Korbyn J. V. Dahlquist, Matthew A. Huggins, ... Christina D. Camell in Nature Aging
    Article 30 April 2024
  5. Myeloid-specific KDM6B inhibition sensitizes glioblastoma to PD1 blockade

    Glioblastoma (GBM) tumors are enriched in immune-suppressive myeloid cells and are refractory to immune checkpoint therapy (ICT). Targeting...

    Sangeeta Goswami, Deblina Raychaudhuri, ... Padmanee Sharma in Nature Cancer
    Article 31 August 2023
  6. Supplementation with α-ketoglutarate improved the efficacy of anti-PD1 melanoma treatment through epigenetic modulation of PD-L1

    Patients with advanced melanoma have shown an improved outlook after anti-PD1 therapy, but the low response rate restricts clinical benefit;...

    Nian Liu, Jianglin Zhang, ... Cong Peng in Cell Death & Disease
    Article Open access 28 February 2023
  7. Genetically Engineered CLDN18.2 CAR-T Cells Expressing Synthetic PD1/CD28 Fusion Receptors Produced Using a Lentiviral Vector

    This study aimed to develop synthetic Claudin18.2 (CLDN18.2) chimeric antigen receptor (CAR)-T (CAR-T) cells as a treatment for advanced gastric...

    Heon Ju Lee, Seo ** Hwang, ... Mi Hee Chang in Journal of Microbiology
    Article Open access 03 May 2024
  8. Peptostreptococcus anaerobius mediates anti-PD1 therapy resistance and exacerbates colorectal cancer via myeloid-derived suppressor cells in mice

    Bacteria such as the oral microbiome member Peptostreptococcus anaerobius can exacerbate colorectal cancer (CRC) development. Little is known...

    Yali Liu, Chi Chun Wong, ... Jun Yu in Nature Microbiology
    Article Open access 15 May 2024
  9. Draft genome sequencing and functional annotation and characterization of biofilm-producing bacterium Bacillus novalis PD1 isolated from rhizospheric soil

    Biofilm forming bacterium Bacillus novalis PD1 was isolated from the rhizospheric soil of a paddy field. B. novalis PD1 is a Gram-positive,...

    S. Ishvaria, Rajathirajan Siva Dharshini, ... Mohandass Ramya in Antonie van Leeuwenhoek
    Article 18 September 2021
  10. Degradation studies of pendimethalin by indigenous soil bacterium Pseudomonas strain PD1 using spectrophotometric scanning and FTIR

    In this study pendimethalin degrading indigenous soil bacterium was isolated from rice field (supplemented with pendimethalin) and identified as, Pseudomonas...

    Neha Trivedi, Ashutosh Dubey in Archives of Microbiology
    Article 19 June 2021
  11. Anti-PD1 therapy induces lymphocyte-derived exosomal miRNA-4315 release inhibiting Bim-mediated apoptosis of tumor cells

    Anti-PD1 immunotherapy, as a single agent or in combination with standard chemotherapies, has significantly improved the outcome of many patients...

    Nina Guyon, Delphine Garnier, ... Pierre-François Cartron in Cell Death & Disease
    Article Open access 11 December 2020
  12. CD83 expression characterizes precursor exhausted T cell population

    T cell exhaustion is a main obstacle against effective cancer immunotherapy. Exhausted T cells include a subpopulation that maintains proliferative...

    Zhiwen Wu, Toshiaki Yoshikawa, ... Yuki Kagoya in Communications Biology
    Article Open access 11 March 2023
  13. circRNA-002178 act as a ceRNA to promote PDL1/PD1 expression in lung adenocarcinoma

    Circular RNAs (circRNAs) have been identified play a vital role in various different types of cancer via sponging miRNAs (microRNAs). However, their...

    JunFeng Wang, XuHai Zhao, ... ShiDong Xu in Cell Death & Disease
    Article Open access 16 January 2020
  14. Multimodal and spatially resolved profiling identifies distinct patterns of T cell infiltration in nodal B cell lymphoma entities

    The redirection of T cells has emerged as an attractive therapeutic principle in B cell non-Hodgkin lymphoma (B-NHL). However, a detailed...

    Tobias Roider, Marc A. Baertsch, ... Sascha Dietrich in Nature Cell Biology
    Article Open access 20 February 2024
  15. Effect of M2-like macrophages of the injured-kidney cortex on kidney cancer progression

    Chronic kidney disease (CKD) affects kidney cancer patients’ mortality. However, the underlying mechanism remains unknown. M2-like macrophages have...

    Taisuke Ishii, Imari Mimura, ... Masaomi Nangaku in Cell Death Discovery
    Article Open access 05 December 2022
  16. Electronic and ring size effects of N-heterocyclic carbenes on the kinetics of ligand substitution reactions and DNA/protein interactions of their palladium(II) complexes

    The synthesis, substitution kinetics and DNA/BSA interactions of four cationic Pd(II) complexes [Pd( 1 )Cl]BF 4 ( Pd1 ), [Pd( 2 )Cl]BF 4 ( Pd2 ), [Pd( 3 )Cl]BF 4 (

    Reinner O. Omondi, Deogratius Jaganyi, Stephen O. Ojwach in BioMetals
    Article Open access 15 May 2023
  17. Proximity proteome map** reveals PD-L1-dependent pathways disrupted by anti-PD-L1 antibody specifically in EGFR-mutant lung cancer cells

    Background

    PD-L1, a transmembrane ligand for immune checkpoint receptor PD1, has been successfully targeted to activate an anti-tumor immune response...

    Anudari Letian, Eyoel Yemanaberhan Lemma, ... Timothy E. McGraw in Cell Communication and Signaling
    Article Open access 13 March 2023
  18. Single-cell sequencing depicts tumor architecture and empowers clinical decision in metastatic conjunctival melanoma

    Conjunctival melanoma (CoM) is a potentially devastating tumor that can lead to distant metastasis. Despite various therapeutic strategies for...

    Hanhan Shi, Hao Tian, ... **anqun Fan in Cell Discovery
    Article Open access 11 June 2024
  19. Fucosylation of HLA-DRB1 regulates CD4+ T cell-mediated anti-melanoma immunity and enhances immunotherapy efficacy

    Immunotherapy efficacy is limited in melanoma, and combinations of immunotherapies with other modalities have yielded limited improvements but also...

    Daniel K. Lester, Chase Burton, ... Eric K. Lau in Nature Cancer
    Article Open access 23 January 2023
  20. Cancer cells resistant to immune checkpoint blockade acquire interferon-associated epigenetic memory to sustain T cell dysfunction

    Prolonged interferon (IFN) signaling in cancer cells can promote resistance to immune checkpoint blockade (ICB). How cancer cells retain effects of...

    **gya Qiu, Bihui Xu, ... Andy J. Minn in Nature Cancer
    Article 16 January 2023
Did you find what you were looking for? Share feedback.